Thank you for stopping by! We have some common sense rules of play for our page community, spelled out below.
(280)
Wilmot Cancer Institute is a National Cancer Institute-Designated Cancer Center leading cancer care and research in 27 counties around Western and Central New York. By participating with URMC/Wilmot Cancer Institute in social networking communities, you agree to comply with these guidelines:
First, we ask that you treat others with respect, even if disagreements occur. Also, please do not post material that could be considered an infringement on the rights of others. URMC reserves the right to delete postings or off-topic comments, or block users, that it deems to be slanderous, obscene, soliciting, harassing, threatening, or otherwise contrary to these guidelines or UR policies. Remember that these are public forums and whatever information you share will be viewed by others. Consider this carefully before posting detailed personal medical information. Furthermore, the information provided by UR Medicine on these platforms is intended for educational purposes only. It is not intended as an endorsement, or a substitute for professional medical advice, diagnosis or treatment. If you are an employee of URMC, please remember that all laws and URMC policies apply, including but not limited to Privacy, HIPAA, Security and Safety. We suggest that you take time to review these policies. We encourage you to consult your manager if you have questions.
01/27/2026
We are excited to share that Randall Kimple, MD, PhD, MBA, FASTRO, has been named the next chair to lead the Department of Radiation Oncology at the University of Rochester.
He will also serve on Wilmot's executive committee, acting as a liaison between the cancer center and other institutes across the University.
Kimple comes to URochester from the University of Wisconsin Carbone Comprehensive Cancer Center, where he's served as a radiation oncologist since 2010. His clinical and research focus is on head and neck cancers, and he has experience developing translational therapies to improve cancer outcomes.
We look forward to welcoming him in person in the coming months. Read more about Dr. Kimple: https://urmc.info/2hi
01/27/2026
January is Radon Action Month! ⚠️ How much do you know about radon and its connection to cancer? Below are answers to common questions people have about radon.
Want to learn more? The UR Institute for Human Health and the Environment (IHHE) has resources available: https://urmc.info/Radon
01/24/2026
01/23/2026
A new American Cancer Society report shares that 70% of cancer patients now live beyond five years. This is up from about 49% in the 1970s.
Wilmot Cancer Institute Director Jonathan Friedberg, MD, MMSc, spoke with WHEC TV about this report. He shared that advances in cancer treatment, driven by research, have played a big role in this change, and that NCI-designated centers like Wilmot are critical to innovations in cancer care.
"Being a place that puts hundreds of patients on clinical trials a year, we are now testing treatments that are going to become standard in the future and it’s a very promising time,” Friedberg said.
ROCHESTER, N.Y. — “As soon as the urologist said, oh it’s cancer…that is an eye-opener,” says Mark Stiegler, reflecting on his diagnosis six years ago. Stiegler has faced bladder cancer and three bouts of lung cancer. “Now, 4 times later and I may be going into my 5th… you don’t feel...
01/22/2026
Thank you to Kinecta for donating activity bags for Wilmot Cancer Center patients, in honor of Martin Luther King Jr. Day. Kinecta team members from across the country also made about 130 cards with uplifting messages to hand out to patients, offering a little compassion during a difficult time.
Wilmot Cancer Institute Volunteer Coordinator Hazel Pugh is pictured here with Drew Myers from Kinecta. Hazel and her team of volunteers will help distribute the bags to patients in the infusion center and inpatient units.
Thank you so much to Kinecta for thinking of our patients. We appreciate your time and kindness!
01/21/2026
Excited to have Dr. Juliet Emamaullee here to lead research within URMC's Transplant team! Her work will include collaborating with Wilmot researchers on clinical trials and other research initiatives.
We're excited to share that Juliet Emamaullee M.D., Ph.D. has been appointed as the inaugural Research Director of the Transplant Institute!
A nationally recognized surgeon-scientist, Emamaullee will lead efforts to expand transplant research, grow clinical trials, and strengthen collaboration across surgery, immunology, and oncology to advance precision, patient-centered transplant care.
If you or someone you know has been looking to quit smoking, now is the time! We are fortunate to have many programs available in the community through the Center for Community Health & Prevention, URMC and Wilmot Cancer Institute.
Call (585) 602-0720 to learn more! 📞
Ramón Cruz, a to***co treatment specialist on our clinical team, was recently recognized by an appreciative patient.
If you want to stop smoking or va**ng, our team at the UR Medicine To***co Treatment Program will build a plan together that meets your needs and timetable. If you are not sure you want to stop yet – or even altogether – we will support you and discuss what you can do to care for your health right now.
Call us at (585) 602-0720 to get started!
01/15/2026
Brian Quealy has had kidney issues since he was a child, and he has had two kidney transplants at Strong Memorial Hospital over the years.
"I love Strong. I tell everybody to go to Strong Memorial. That's how highly I believe in them. It's not just one person. It's a team. And that’s what I really like."
So, when he was diagnosed with breast cancer in March 2024, he knew he had to return to the hospital system he trusted so much. While he got some of his care at home in the Elmira area, he came to Pluta Cancer Center for chemotherapy.
"I would rather go to someplace associated with Strong," he says. "I'm so glad I went to Pluta. I loved it. Everybody was great."
Today, he's finished treatment and is doing well. He enjoys hunting, coaching youth baseball, going to church, and working at a local golf course. Whenever he gets the chance, he's happy to talk to other people about cancer - both to help support them after a diagnosis and to encourage them to seek help if something feels off.
"Don't think of it as only women get it," he says. "If you have any kind of distortion in your breast, get it checked."
He's pictured here with his wife, JoAnn.
01/14/2026
In January, we recognize all who have been impacted by cervical cancer. 🙏
We are dedicated to supporting those who've faced a diagnosis and to improving outcomes for everyone facing this cancer.
01/11/2026
𝘏𝘦𝘺-𝘦𝘺-𝘦𝘺-𝘦𝘺! Let's go, Buffalo! 💙🐃 ❤
01/09/2026
Finding out he had a type of brain tumor called an astrocytoma rocked Art Sullivan's world - but timing was on his side.
He started taking a new drug called vorasidenib, one of the first new treatments for astrocytoma in decades. It's changed his life because it's keeping the tumor at bay but has very minimal side effects.
This matters because it means he's able to continue working, running, and spending time with his wife and two young boys.
“I feel super lucky,” says Sullivan. “The way the drug was approved when I needed it—it was almost like it was for me. Having some hope is nice.”
Be the first to know and let us send you an email when Wilmot Cancer Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Wilmot Cancer Institute welcomes your participation on our page and encourages you to interact with us often and to comment about the content you find here.
We do not discriminate against any views, but administrators of official UR Medicine Wilmot Cancer Institute pages do reserve the right to delete the following or to block users who post the following:
Obscenity, nudity, defamation or hate speech (speech that targets people or groups based on race, ethnicity, religion, gender, or any other protected status.)
Comments/posts that threaten to harm individuals, groups, or organizations.
Commercial advertisements or solicitations of funds.
Endorsement or encouragement of illegal activities.
Multiple off-topic posts or repetitive posts that are copied and pasted.
Personal information including but not limited to email addresses, telephone numbers, mailing addresses, or identification numbers.
Remember that these are public forums and whatever information you share will be viewed by others. Consider this carefully before posting detailed personal medical information.
Furthermore, the information provided by Wilmot Cancer Institute on these platforms is intended for educational purposes only. It is not intended as an endorsement, or a substitute for professional medical advice, diagnosis or treatment.
If you are an employee of URMC/Wilmot, please remember that all laws and URMC policies apply, including but not limited to Privacy/HIPAA, Security and Safety. We suggest that you take time to review these policies and encourage you to consult your manager if you have questions.
